VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Aug. 11, 2006) - Pyng Medical (TSX VENTURE:PYT) is pleased to announce that Dr. Alan L. Moloff, COL (retired) United States Army has recently joined Pyng Medical's board of directors. Dr. Moloff has replaced Mr Peter Dittmer who has resigned for personal reasons.
Dr. Moloff joins the board after an impressive military medical career with his last assignment as Commanding Officer of the Defense Medical Readiness Training Institute, Ft. Sam, Houston, Texas. Prior US Army Assignments included: Commander, Army Aeromedical Center, Fort Rucker, Alabama; Commander and Joint Task Force Surgeon, 212th MASH; Surgeon V Corps, Southern European Task Force; Surgeon with various US Special Forces Units and the 82nd Airborne Division. Dr. Moloff's medical specialty education includes aerospace medicine and undersea medicine. Most recently, Dr. Moloff has been named to the board of a new medical specialty in Disaster Medicine. Dr. Moloff is currently the president of the Special Operations Medical Association and has additional professional memberships including: Aerospace Medical Association; Army Aviation Medical Association; American Osteopathic Association; Association of Military Surgeons of the US; and, Society of US Army Flight Surgeons. Dr. Moloff and his wife Colleen Morrisette live in Reno, Nevada.
Pyng Medical has also released the second issue of its quarterly newsletter. This quarterly newsletter is meant to communicate to Pyng users and investors recent developments in Pyng Medical. The newsletter is available on Pyng's website and interested parties are encouraged to enroll in order to stay abreast of developments at Pyng.
Pyng Medical has retained the services of Caldwell Partners to undertake the search for our new CEO. A national advertising campaign has commenced and candidates are being screened.
Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
FOR FURTHER INFORMATION PLEASE CONTACT:
Pyng Medical Corp.